Literature DB >> 19794814

Why does GM1 induce a potent beneficial response to experimental Chagas disease?

S Cossy Isasi, C A Condat, G J Sibona.   

Abstract

Being one of the world's neglected diseases, Chagas has neither a vaccine nor a satisfactory therapy. Inoculation of murine models with the ganglioside GM1 has shown a strikingly nonlinear effect, leading to a strong decrease in parasite load at low doses but reverting to a load increase at high doses. Cardiocyte destruction concomitant with the disease is also significantly reduced by a moderate application of GM1. A mathematical model for the interaction between the parasite and the immune system is shown to explain these effects and is used to predict an optimal dosage that maximizes parasite removal with minimal cardiocyte destruction.

Entities:  

Year:  2009        PMID: 19794814      PMCID: PMC2707790          DOI: 10.2976/1.3067922

Source DB:  PubMed          Journal:  HFSP J        ISSN: 1955-205X


  44 in total

1.  Ca2+/calmodulin-dependent protein kinase II is a modulator of CARMA1-mediated NF-kappaB activation.

Authors:  Kazuhiro Ishiguro; Todd Green; Joseph Rapley; Heather Wachtel; Cosmas Giallourakis; Aimee Landry; Zhifang Cao; Naifang Lu; Ando Takafumi; Hidemi Goto; Mark J Daly; Ramnik J Xavier
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

2.  A simple model for the interaction between T. cruzi and its antibodies during Chagas infection.

Authors:  S C Isasi; G J Sibona; C A Condat
Journal:  J Theor Biol       Date:  2001-01-07       Impact factor: 2.691

3.  Fluorescence polarization studies of rat intestinal microvillus membranes.

Authors:  D Schachter; M Shinitzky
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

4.  Chronic murine Chagas' disease: the impact of host and parasite genotypes.

Authors:  John Andersson; Anders Orn; Dan Sunnemark
Journal:  Immunol Lett       Date:  2003-04-03       Impact factor: 3.685

5.  Gangliosides modulate the activity of the plasma membrane Ca(2+)-ATPase from porcine brain synaptosomes.

Authors:  Yongfang Zhao; Xiaoxuan Fan; Fuyu Yang; Xujia Zhang
Journal:  Arch Biochem Biophys       Date:  2004-07-15       Impact factor: 4.013

6.  Effect of gangliosides on Trypanosoma cruzi infection in mice.

Authors:  H D Luján; P Paglini; R Fretes; A Fernández; G D Fidelio; D H Bronia
Journal:  Life Sci       Date:  1993       Impact factor: 5.037

7.  A 9,000-year record of Chagas' disease.

Authors:  Arthur C Aufderheide; Wilmar Salo; Michael Madden; John Streitz; Jane Buikstra; Felipe Guhl; Bernardo Arriaza; Colleen Renier; Lorentz E Wittmers; Gino Fornaciari; Marvin Allison
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-06       Impact factor: 11.205

8.  Trypanosoma cruzi: biological characterization of clones derived from chronic chagasic patients. II. Quantitative analysis of the intracellular cycle.

Authors:  J C Engel; P S Doyle; J A Dvorak
Journal:  J Protozool       Date:  1985-02

9.  Changes in Trypanosoma cruzi infectivity by treatments that affect calcium ion levels.

Authors:  M A Yakubu; S Majumder; F Kierszenbaum
Journal:  Mol Biochem Parasitol       Date:  1994-07       Impact factor: 1.759

10.  Mechanism for ganglioside-mediated modulation of a calmodulin-dependent enzyme. Modulation of calmodulin-dependent cyclic nucleotide phosphodiesterase activity through binding of gangliosides to calmodulin and the enzyme.

Authors:  H Higashi; T Yamagata
Journal:  J Biol Chem       Date:  1992-05-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.